483
Raptor Pharmaceuticals Inc.Raptor Pharmaceuticals Inc. – FDA 483, Aug 24, 2016
Record Details
Raptor Pharmaceuticals Inc., a drug manufacturer in Novato, CA, was inspected and cited for two significant issues. The firm failed to report twenty-seven serious and unexpected adverse drug experiences for its product PROCYSBI to the FDA within the required 15 calendar days. Additionally, their procedures for handling drug product complaints were found deficient, particularly concerning adverse events reported via social media and the lack of complaint trending.
View Company Profile
ID · 841f35d6-c4e6-4deb-ba88-ee28ded0a6b9
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.